Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

ACC, AHA outline calculation of cost-effectiveness in guidelines | Next generation Watchman LAAC device enters trial in 2026

News You Need to Know Today
ACC, AHA outline calculation of cost-effectiveness in guidelines | Next generation Watchman LAAC device enters trial in 2026
Thursday, October 2, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Next-generation Watchman enters trial in 2026 as LAAO volume grows

The next-generation Watchman device is designed to better seal off complex LAA anatomy in a variety of LAA shapes and sizes.

READ MORE >
The next generation Watchman device is designed to better seal off complex LAA anatomy to prevent strokes in atrial fibrillation patients. It uses an optimized architecture to fill gaps and adapt to the unique characteristics of each patient's appendage, which come in a wide variety of shapes and sizes.
Share on Twitter Share on Facebook Share on Linkedin

Next-generation Watchman enters trial in 2026 as LAAO volume grows

Share on Twitter Share on Facebook Share on Linkedin
The next generation Watchman device is designed to better seal off complex LAA anatomy to prevent strokes in atrial fibrillation patients. It uses an optimized architecture to fill gaps and adapt to the unique characteristics of each patient's appendage, which come in a wide variety of shapes and sizes.
The next-generation Watchman device is designed to better seal off complex LAA anatomy in a variety of LAA shapes and sizes.
READ MORE >

ACC and AHA outline calculation of cost-effectiveness in clinical practice guidelines

Healthcare's cost-conscious environment prompted the ACC and AHA to develop a statement on the value methodology to be used when creating clinical practice guidelines.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

ACC and AHA outline calculation of cost-effectiveness in clinical practice guidelines

Share on Twitter Share on Facebook Share on Linkedin
Healthcare's cost-conscious environment prompted the ACC and AHA to develop a statement on the value methodology to be used when creating clinical practice guidelines.
READ MORE >

Featured Articles

FastWave lines up principal investigators for pivotal intravascular lithotripsy trial

"The key question isn't just whether a device works, but whether it makes procedures more efficient and provides physicians with a more predictable tool for treating patients with complex arterial disease," explained co-principal investigator Venita Chandra, MD, clinical professor of surgery at Stanford Health Care.

READ MORE >
The Artero peripheral electric IVL (E-IVL) system is about to enter its US FDA IDE trial.
Share on Twitter Share on Facebook Share on Linkedin

FastWave lines up principal investigators for pivotal intravascular lithotripsy trial

Share on Twitter Share on Facebook Share on Linkedin
The Artero peripheral electric IVL (E-IVL) system is about to enter its US FDA IDE trial.
"The key question isn't just whether a device works, but whether it makes procedures more efficient and provides physicians with a more predictable tool for treating patients with complex arterial disease," explained co-principal investigator Venita Chandra, MD, clinical professor of surgery at Stanford Health Care.
READ MORE >

Putting more emphasis on prevention in heart failure care

Martha Gulati, MD, co-chair on a new joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology, discusses the dire need she sees to boost prevention efforts for heart failure.

READ MORE >
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, director of prevention, associate director, Barbra Streisand Women's Heart Center, Cedars-Sinai, and past president of the American Society for Preventive Cardiology (ASPC), was co-chair on a new joint scientific statement from the Heart Failure Society of America, and the ASPC on the need to boost prevention efforts for heart failure. She explains the new scientific statement that calls for greater prevention efforts in heart failure.
Share on Twitter Share on Facebook Share on Linkedin

Putting more emphasis on prevention in heart failure care

Share on Twitter Share on Facebook Share on Linkedin
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, director of prevention, associate director, Barbra Streisand Women's Heart Center, Cedars-Sinai, and past president of the American Society for Preventive Cardiology (ASPC), was co-chair on a new joint scientific statement from the Heart Failure Society of America, and the ASPC on the need to boost prevention efforts for heart failure. She explains the new scientific statement that calls for greater prevention efforts in heart failure.
Martha Gulati, MD, co-chair on a new joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology, discusses the dire need she sees to boost prevention efforts for heart failure.
READ MORE >

SCAI outlines broken Medicaid reimbursement model for congenital heart disease

SCAI says many children and adults living with congenital heart disease are being left behind by a payment system that does not adequately value their care.

READ MORE >
 3D printed congenital single ventricle patient from a CT scan, displayed at RSNA 2023 by Medviso. Models like this can help in surgical preplanning and peri-procedural guidance.#RSNA #RSNA23 #RSNA2024 #SCAI
Share on Twitter Share on Facebook Share on Linkedin

SCAI outlines broken Medicaid reimbursement model for congenital heart disease

Share on Twitter Share on Facebook Share on Linkedin
 3D printed congenital single ventricle patient from a CT scan, displayed at RSNA 2023 by Medviso. Models like this can help in surgical preplanning and peri-procedural guidance.#RSNA #RSNA23 #RSNA2024 #SCAI
SCAI says many children and adults living with congenital heart disease are being left behind by a payment system that does not adequately value their care.
READ MORE >

AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

READ MORE >
mammogram mammography breast cancer
Share on Twitter Share on Facebook Share on Linkedin

AI turns mammograms into CVD risk assessments—no outside data required

Share on Twitter Share on Facebook Share on Linkedin
mammogram mammography breast cancer
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
READ MORE >

Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients

Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.
READ MORE >

FDA approves treatment of rare genetic disorder in children as young as 1 year old

Evinacumab-dgnb, sold by Regeneron under the brand name Evkeeza, can now be used to treat homozygous familial hypercholesterolemia in much younger patients.

READ MORE >
Evinacumab-dgnb is sold by Regeneron under the brand name Evkeeza
Share on Twitter Share on Facebook Share on Linkedin

FDA approves treatment of rare genetic disorder in children as young as 1 year old

Share on Twitter Share on Facebook Share on Linkedin
Evinacumab-dgnb is sold by Regeneron under the brand name Evkeeza
Evinacumab-dgnb, sold by Regeneron under the brand name Evkeeza, can now be used to treat homozygous familial hypercholesterolemia in much younger patients.
READ MORE >

U.S. considering new tariffs for heart valves, imaging equipment and other medical devices

The Department of Commerce is seeking more information about how current trade policies are impacting the U.S. medtech industry. The investigation could lead to the creation of new tariffs. Public comments are being accepted until Oct. 17, and the findings will be presented to President Donald Trump.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

U.S. considering new tariffs for heart valves, imaging equipment and other medical devices

Share on Twitter Share on Facebook Share on Linkedin
The Department of Commerce is seeking more information about how current trade policies are impacting the U.S. medtech industry. The investigation could lead to the creation of new tariffs. Public comments are being accepted until Oct. 17, and the findings will be presented to President Donald Trump.
READ MORE >

In Other News

Emergency departments’ use of CT imaging has increased substantially since 2013

This uptick was attributed to more scans being administered per ED visit, rather than a rise in overall patient volumes, an analysis of Medicare data found. 

READ MORE >
Medicare data stethoscope healthcare trends graphs finance financials
Share on Twitter Share on Facebook Share on Linkedin

Emergency departments’ use of CT imaging has increased substantially since 2013

Share on Twitter Share on Facebook Share on Linkedin
Medicare data stethoscope healthcare trends graphs finance financials
This uptick was attributed to more scans being administered per ED visit, rather than a rise in overall patient volumes, an analysis of Medicare data found. 
READ MORE >

FDA grants Breakthrough Device status to artificial intelligence triage solution from Aidoc

The New York-based radiology vendor announced the news Tuesday, with it applying to a novel product that flags a wide array of life-threatening, time-sensitive conditions in CT scans. 

READ MORE >
carestream_3.jpg
Share on Twitter Share on Facebook Share on Linkedin

FDA grants Breakthrough Device status to artificial intelligence triage solution from Aidoc

Share on Twitter Share on Facebook Share on Linkedin
carestream_3.jpg
The New York-based radiology vendor announced the news Tuesday, with it applying to a novel product that flags a wide array of life-threatening, time-sensitive conditions in CT scans. 
READ MORE >

Trump, Pfizer announce ‘TrumpRx’ following tariff exemption deal

The new "TrumpRx.com" will sell Pfizer drugs at a heavily discounted price, direct-to-consumers. However, details on the initiative are not entirely clear. 

READ MORE >
President Donald Trump with MAGA hat, White House press photo
Share on Twitter Share on Facebook Share on Linkedin

Trump, Pfizer announce ‘TrumpRx’ following tariff exemption deal

Share on Twitter Share on Facebook Share on Linkedin
President Donald Trump with MAGA hat, White House press photo
The new "TrumpRx.com" will sell Pfizer drugs at a heavily discounted price, direct-to-consumers. However, details on the initiative are not entirely clear. 
READ MORE >

Judge orders DOJ to stop commenting on Mangione’s guilt, political leanings

A U.S. district court judge has ordered the Department of Justice to explain why its officials continue to comment on the trial, in violation of her order. The agency has until the end of this week to respond. 

READ MORE >
Mangione PA Police Photo
Share on Twitter Share on Facebook Share on Linkedin

Judge orders DOJ to stop commenting on Mangione’s guilt, political leanings

Share on Twitter Share on Facebook Share on Linkedin
Mangione PA Police Photo
A U.S. district court judge has ordered the Department of Justice to explain why its officials continue to comment on the trial, in violation of her order. The agency has until the end of this week to respond. 
READ MORE >

Radiology lessons learned from the 2023 terror attacks in Israel

Soroka University Medical Center served as the primary evacuation destination after the attack, accepting nearly 700 injured patients, most of whom needed medical imaging.

READ MORE >
Radiology providers from Israel share how their hospital handled the mass casualties caused by the October 2023 terror attacks.
Share on Twitter Share on Facebook Share on Linkedin

Radiology lessons learned from the 2023 terror attacks in Israel

Share on Twitter Share on Facebook Share on Linkedin
Radiology providers from Israel share how their hospital handled the mass casualties caused by the October 2023 terror attacks.
Soroka University Medical Center served as the primary evacuation destination after the attack, accepting nearly 700 injured patients, most of whom needed medical imaging.
READ MORE >

AI-driven medical benefits servicer hit with data breach

Healthcare Interactive confirmed the cyberattack in a statement released last week; however the details have yet to be reported to HHS. The incident happened in July. 

READ MORE >
cybersecurity hacker ransomware cyber data breach
Share on Twitter Share on Facebook Share on Linkedin

AI-driven medical benefits servicer hit with data breach

Share on Twitter Share on Facebook Share on Linkedin
cybersecurity hacker ransomware cyber data breach
Healthcare Interactive confirmed the cyberattack in a statement released last week; however the details have yet to be reported to HHS. The incident happened in July. 
READ MORE >

Industry News

 

Five reasons to switch to Cardiac PET/CT

Sponsored by CDL Nuclear Technologies

Discover the five powerful reasons leading cardiology practices are switching to Cardiac PET/CT. This breakthrough technology delivers unmatched accuracy in detecting heart disease. Our ebook breaks down exactly how Cardiac PET/CT improves outcomes, boosts efficiency, and transforms patient care.  
READ MORE >
 

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Teen's death at center of new lawsuit | Surgery outperforms GLP-1 drugs | Long-term antidepressant use & SCD
AI helps 3D imaging labs evolve | Catheters recalled over safety risk | New ways to predict TAVR outcomes
Looking Back: Cardiologist fired for speaking out | Hospital sues practice | Strokes after PFA | Energy drinks & heart disease
Surgery outperforms GLP-1 drugs | CEPDs fail to make an impact | Redo TAVR: Supra-annular vs. intra-annular valves
Week in Review: FDA clears imaging platform | Vascular device linked to deaths | GLP-1 drugs & AFib | Pacemakers recalled again
Optimism about cardiology’s future | HRS leader looks ahead | Women live longer after TAVR | J&J announces acquisition
Preventing the most common complication after heart surgery | When bioprosthetic valves fail | Good news for Medtronic

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …4
    • Page 5
    • Page 6
    • Page 7
    • Current page 8
    • Page 9
    • Page 10
    • Page 11
    • Page 12 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup